Compare BLCO & CWEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLCO | CWEN |
|---|---|---|
| Founded | 1853 | 2012 |
| Country | Canada | United States |
| Employees | 13000 | N/A |
| Industry | Ophthalmic Goods | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 6.3B |
| IPO Year | 2022 | 2013 |
| Metric | BLCO | CWEN |
|---|---|---|
| Price | $16.94 | $29.14 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 13 |
| Target Price | $19.04 | ★ $41.85 |
| AVG Volume (30 Days) | 288.1K | ★ 945.7K |
| Earning Date | 10-28-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 6.49% |
| EPS Growth | N/A | ★ 11.94 |
| EPS | N/A | ★ 0.75 |
| Revenue | ★ $5,101,000,000.00 | $1,429,000,000.00 |
| Revenue This Year | $7.71 | $18.76 |
| Revenue Next Year | $5.86 | $12.21 |
| P/E Ratio | ★ N/A | $39.28 |
| Revenue Growth | ★ 6.47 | 4.23 |
| 52 Week Low | $13.77 | $28.83 |
| 52 Week High | $18.92 | $41.74 |
| Indicator | BLCO | CWEN |
|---|---|---|
| Relative Strength Index (RSI) | 49.12 | 32.45 |
| Support Level | $16.94 | N/A |
| Resistance Level | $17.21 | $34.92 |
| Average True Range (ATR) | 0.39 | 0.68 |
| MACD | -0.03 | -0.11 |
| Stochastic Oscillator | 45.28 | 0.78 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Clearway Energy Inc is a publicly-traded energy infrastructure investor with a focus on investments in clean energy and the owner of modern, sustainable, and long-term contracted assets across North America. The company segments its operations into Flexible Generation, Renewables & Storage, and Corporate divisions. The majority of its revenue is generated from the Renewables & Storage segment.